The global veterinary biologics market is poised for significant growth in the coming decade, with a projected market value exceeding US$24 billion by 2034. This upward trend signifies a compound annual growth rate (CAGR) of 6.3% from 2024, reflecting the increasing focus on animal health and the vital role of veterinary biologics in disease prevention and treatment.
Veterinary biologics encompass a wide range of products like vaccines, antigens, and antitoxins derived from living organisms or genetically engineered materials. These play a critical role in safeguarding animal health by preventing infectious diseases, promoting immune response, and neutralizing toxins.
Veterinary biologics encompass vaccines, antigens, antitoxins, and other biological products used to diagnose, treat, and prevent diseases in animals.
Preview Next-Level Insights Sample :
https://www.futuremarketinsights.com/reports/sample/rep-gb-2288
The rising demand for these products can be attributed to several key factors:
- Growing Focus on Pet Health: Pet ownership continues to rise globally, and pet owners are increasingly prioritizing their animals’ health and well-being. This translates to a greater demand for preventative healthcare solutions like vaccinations.
- Emphasis on Animal Welfare: Regulatory bodies and animal welfare organizations are placing greater emphasis on responsible pet ownership and disease prevention in livestock. Veterinary biologics play a crucial role in achieving these goals.
- Emergence of New Zoonotic Diseases: The growing threat of zoonotic diseases, those transmissible between animals and humans, underscores the importance of animal health management. Effective vaccination programs using veterinary biologics are critical to mitigating zoonotic disease outbreaks.
Key Highlights
- The increasing demand for specialized biologics for companion animals, including dogs, cats, and horses, presents a significant market opportunity. Companion animal healthcare has become a focus area for veterinary biologics manufacturers.
- The emergence of new and evolving infectious diseases in animals, such as avian influenza and African swine fever, creates opportunities for the development of specific vaccines and biologics to prevent and control these diseases.
- There is an increased focus on the health of animals to meet international standards, as trade in animal products becomes more globalized, which drives the demand for effective veterinary biologics to ensure the health and safety of animals in different regions.
- Increasing awareness among veterinarians, farmers, and pet owners about the benefits of preventive healthcare and the availability of veterinary biologics has a positive impact on market growth. Education campaigns and training programs play a crucial role in promoting the adoption of these products.
Understand Our Methodological Process:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2288
Competitive Landscape:
Within the larger animal health industry, the veterinary biologics sector is a vibrant and competitive market. The market includes a broad spectrum of biologically produced products intended for animal illness prevention and treatment.
The competitive environment is defined by the existence of well-known biotechnology corporations, pharmaceutical companies, and makers of specialty veterinary products. A thorough analysis of the market’s competitive dynamics, major players, strategic initiatives, and market trends is provided in the detailed note.
Key Veterinary Biologics Market Players:
- Elanco Animal Health
- Ceva
- Phibro Animal Health Corporation
- Boehringer Ingelheim
- Zoetis Inc.
- Merck & Co. Inc.
- Virbac
- Hester Biosciences Limited
- Colorado Serum Company
- Addison Biological Laboratory Inc.
- American Animal Health Inc.
- HIPRA
- Bimeda Inc. (Texas Vet Lab Inc.)
Key Segments in the Veterinary Biologics Market Report:
Product:
- Vaccines
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Bacterial Extracts
- Monoclonal Antibody
- Immunomodulatory
- Cytokines
- Others
- Allergenic Extracts
Animal:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Obtain In-Depth Market Insights: Purchase Now to Access: https://www.futuremarketinsights.com/checkout/2288
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
